Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation

Benzer Materyaller

• The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation
  Yazar:: Li, Minghui, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Mouse host unlicensed NK cells promote donor allogeneic bone marrow engraftment
  Yazar:: Alvarez, Maite, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation
  Yazar:: Welniak, Lisbeth A., ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
  Yazar:: Sun, Kai, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• IFN-γ Receptor Deficient Donor T cells Mediate Protection from Graft-versus-Host Disease and Preserve Graft-versus-Tumor Responses After Allogeneic Bone Marrow Transplantation
  Yazar:: Sun, Kai, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)